Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy (vol 368, pg 138, 2013)

被引：0
|
作者：
Ryan, Charles J.
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [31] Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer
    Cheetham, Philippa J.
    Petrylak, Daniel P.
    EUROPEAN UROLOGY, 2012, 61 (04) : 850 - 850
  • [32] Alcohol Use in Adults (vol 368, pg 365, 2013)
    Friedmann, P. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 781 - 781
  • [33] Use of abiraterone acetate in advanced metastatic prostate cancer
    Marquez Fernandez, E.
    Marmesat Rodas, B.
    Quesada Sanz, M. P.
    Gallego Galisteo, M.
    Ramos Baez, J. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 994 - 994
  • [34] Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
    de Wit, Ronald
    de Bono, Johann
    Sternberg, Cora N.
    Fizazi, Karim
    Tombal, Bertrand
    Wuelfing, Christian
    Kramer, Gero
    Eymard, Jean-Christophe
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerdur
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    Castellano, Daniel
    de Wit, Ronald
    de Bono, Johann
    Sternberg, Cora N.
    Fizazi, Karim
    Tombal, Bertrand
    Wulfing, Christian
    Kramer, Gero
    Eymard, Jean-Christophe
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerour
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    Castellano, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26): : 2506 - 2518
  • [35] Something for Everyone (vol 138, pg 22, 2013)
    Fox, Bette-Lee
    LIBRARY JOURNAL, 2014, 139 (01) : 10 - 10
  • [36] Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer
    Matsubara, Nobuaki
    Yamada, Yoko
    Tabata, Ken-ichi
    Satoh, Takefumi
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Kawahara, Takashi
    Uemura, Hiroji
    Yano, Akihiro
    Kawakami, Satoru
    Otsuka, Masafumi
    Fukasawa, Satoshi
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 142 - 148
  • [37] The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer
    Boerrigter, Emmy
    Benoist, Guillemette E.
    Overbeek, Joanneke K.
    Donders, Rogier
    Mehra, Niven
    van Oort, Inge M.
    Ter Heine, Rob
    van Erp, Nielka P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1170 - 1178
  • [38] Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide (vol 7, pg 235, 2013)
    El-Amm, Joelle
    Patel, Nihar
    Freemanand, Ashley
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 291 - 291
  • [39] Genetically Informed Therapy in Leukemia (vol 368, pg 1838, 2013)
    Radich, Jerald
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09): : 886 - 886
  • [40] Abiraterone Acetate In Metastatic Castration-Resistant Prostate Cancer
    Yang, Lily P. H.
    DRUGS, 2011, 71 (15) : 2067 - 2077
12345